11 results
Pharmacological Treatment of Hepatorenal Syndrome (HRS)

Midodrine - Alpha agonist incr blood pressure incr renal perfusion pressure
Pharmacological Treatment ... pressure incr renal ... edgarvlermamd - Nephrology ... #Management #Pharmacology ... #Medications #Treatment
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... COVID 19 - Zika virus ... Treatment: • Plasmapheresis ... Syndrome #diagnosis #management ... #treatment #neurology
Hematuria in Post-Renal Transplant Patient
Prevalence up to 12% in the postrenal transplant patient
 • Bacterial: Escherichia
Hematuria in Post-Renal ... Herpes Simple Virus ... #Hematuria #Renal ... #blood #urine #management ... #treatment #nephrology
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Immunodeficiency Virus ... per day, with renal ... #management #meningitis ... #cryptococcus #HIVAIDS
Vancomycin Associated Acute Kidney Injury

 • Drug induced acute kidney injury is generally defined as a
particularly underlying renal ... • Treatment includes ... Vancomycin #AKI #pharmacology ... toxicology #diagnosis #management ... #nephrology
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... and cauda equina TREATMENT ... SinaiBmoreIMRes #GBS #Guillain ... Syndrome #diagnosis #management ... #neurology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Agents Regulating Renal ... irrigation • Management ... Tolvaptan) • Treatment ... Excretion #Diuresis #Nephrology ... #Pharmacology #
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Herpes Simplex Virus ... • Continue treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Varicella Zoster Virus ... , treatment with ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Bartonella Infections in HIV-AIDS
Preferred Therapy
For Bacillary Angiomatosis, Peliosis Hepatis, Bacteremia, and Osteomyelitis:
patients with renal ... course of primary treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology